Shuttle Pharmaceuticals Holdings, Inc. — Form 8-K/A
Filed September 24, 2026 · analyzed by the 8-K Agent
8-K/A
— Neutral
significance 18/100
What the filing says
Shuttle Pharmaceuticals filed an amended Form 8-K on 2026-09-24 for the period ending 2026-09-09. The filing contains Item 9.01 (Financial Statements and Exhibits) but the specific amendments, counterparties, dollar amounts, share counts, or material events are not disclosed in the header metadata provided. Without access to the full amendment text, concrete changes cannot be identified.
Why this rating
8-K/A amendments are routine regulatory filings. No material transaction, event, or financial impact is evident from metadata alone.
Extracted items
See more from September 24, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.